Financhill
Back

Biogen 10K Form

Sell
23

BIIB
Biogen

Last Price:
220.00
Seasonality Move:
-2.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BIIB News And Ratings

See the #1 stock for the next 7 days that we like better than BIIB

BIIB Financial Statistics

Sales & Book Value

Annual Sales: $9.84B
Cash Flow: $-52.7M
Price / Cash Flow: 26.08
Annual Sales: $102.14
Price / Book: 2.18

Profitability

EPS (TTM): 7.98000
Net Income (TTM): $1.16B
Gross Margin: $7.3B
Return on Equity: 8.19%
Return on Assets: 4.49%

Biogen Earnings Forecast

Key Biogen Financial Ratios

  • The Gross Profit Margin over the past 40 years for BIIB is 74.24%.
  • The Selling, General & Administrative Expenses for BIIB have been equal to 25.92% of Gross Profit Margin.
  • The Research & Development expenses have been 25.03% of Revenue.
  • The Interest Expense is 21.26% of Operating Income.
  • The Net Earning history of BIIB is 11.81% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 27 years.

Biogen Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Drug Manufacturers - General
Sector: Healthcare
Current Symbol: BIIB
CUSIP: 09062X
Website: biogen.com

Debt

Debt-to-Equity Ratio: 0.47
Current Ratio: 2
Quick Ratio: 0.92

Price-to-Earnings

Trailing P/E Ratio: 27.82
Forward P/E Ratio: 12.62

BIIB Technical Analysis vs Fundamental Analysis

Sell
23
Biogen (BIIB) is a Sell

Is Biogen a Buy or a Sell?

  • Biogen stock is rated a Sell
    The current Biogen [BIIB] share price is $221.74. The Score for BIIB is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.